|
1
|
Feuerstein JD, Moss AC and Farraye FA:
Ulcerative Colitis. Mayo Clin Proc. 94:1357–1373. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rubin DT, Ananthakrishnan AN, Siegel CA,
Sauer BG and Long MD: ACG Clinical Guideline: Ulcerative Colitis in
Adults. Am J Gastroenterol. 114:384–413. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakov R: New markers in ulcerative
colitis. Clin Chim Acta. 497:141–146. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ko CW, Singh S, Feuerstein JD, Falck-Ytter
C, Falck-Ytter Y and Cross RK; American Gastroenterological
Association Institute Clinical Guidelines Committee, : AGA Clinical
practice guidelines on the management of Mild-to-Moderate
ulcerative colitis. Gastroenterology. 156:748–764. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cross R, Ko CW and Singh S:
Mild-to-Moderate ulcerative colitis guideline. Gastroenterology.
156:7682019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Teschke R, Wolff A, Frenzel C, Eickhoff A
and Schulze J: Herbal traditional Chinese medicine and its evidence
base in gastrointestinal disorders. World J Gastroenterol.
21:4466–4490. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fan Y, Yi W, Huang H, Mei Z and Feng Z:
Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative
colitis: A systematic review of randomized controlled trials.
Medicine (Baltimore). 98:e185122019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shen Z, Zhou Q, Ni Y, He W, Shen H and Zhu
L: Traditional Chinese medicine for mild-to-moderate ulcerative
colitis: Protocol for a network meta-analysis of randomized
controlled trials. Medicine. 98:e168812019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin JC, Wu JQ, Wang F, Tang FY, Sun J, Xu
B, Jiang M, Chu Y, Chen D, Li X, et al: QingBai decoction regulates
intestinal permeability of dextran sulphate sodium-induced colitis
through the modulation of notch and NF-κB signalling. Cell Prolif.
52:e125472019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang XM, Tian G, Duan QJ, Wu DQ, Shao J,
Wang TM and Wang CZ: Therapeutic potential of n-butanol extract of
Pulsatilla decoction in a murine model of ulcerative colitis
induced by DSS combined with Candida albicans colonization.
Zhongguo Zhong Yao Za Zhi. 43:2979–2984. 2018.(In Chinese).
PubMed/NCBI
|
|
11
|
Wang WH, Zhan ZL, Peng HS, Yang J and Qian
JP: Textual research on the origin and producing area of Baitouweng
(Radix Pulsatillae). Zhonghua Yi Shi Za Zhi. 47:14–18. 2017.(In
Chinese). PubMed/NCBI
|
|
12
|
Yu Z, Liu HJ, Dun HH, Dong Q and Liang C:
Effect of Pulsatilla decoction on the expression of proinflammatory
cytokines in inflammatory bowel disease. Zhongguo Ying Yong Sheng
Li Xue Za Zhi. 27:416–419. 2011.(In Chinese). PubMed/NCBI
|
|
13
|
Pontoglio M: Hepatocyte nuclear factor 1,
a transcription factor at the crossroads of glucose homeostasis. J
Am Soc Nephrol. 11 (Suppl 16):S140–S143. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang X, Fan F and Cao Q: Modified
Pulsatilla decoction attenuates oxazolone-induced colitis in mice
through suppression of inflammation and epithelial barrier
disruption. Mol Med Rep. 14:1173–1179. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu SW, Liu HJ, Zhao W, Li L, Dun HH and
Liang C: Molecular mechanisms involved in the treatment of
inflammatory bowel disease by Pulsatilla decoction. Zhongguo Ying
Yong Sheng Li Xue Za Zhi. 27:106–109. 2011.(In Chinese). PubMed/NCBI
|
|
16
|
Hua YL, Ma Q, Zhang XS, Jia YQ, Peng XT,
Yao WL, Ji P, Hu JJ and Wei YM: Pulsatilla decoction can treat the
dampness-heat diarrhea rat model by regulating glycerinphospholipid
metabolism based lipidomics approach. Front Pharmacol. 11:1972020.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu X, He S, Li Q, Mu X, Hu G and Dong H:
Comparison of the Gut microbiota between pulsatilla decoction and
levofloxacin hydrochloride therapy on Escherichia coli
Infection. Front Cell Infect Microbiol. 10:3192020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Yang J, Cao Q and Tang J:
Therapeutic efficacy and mechanism of water-soluble extracts of
Banxiaxiexin decoction on BALB/c mice with oxazolone-induced
colitis. Exp Ther Med. 8:1201–1204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ji AL, Li T, Zu G, Feng DC, Li Y, Wang GZ,
Yao JH and Tian XF: Ubiquitin-specific protease 22 enhances
intestinal cell proliferation and tissue regeneration after
intestinal ischemia reperfusion injury. World J Gastroenterol.
25:824–836. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gordon IO, Agrawal N, Willis E, Goldblum
JR, Lopez R, Allende D, Liu X, Patil DY, Yerian L, El-Khider F, et
al: Fibrosis in ulcerative colitis is directly linked to severity
and chronicity of mucosal inflammation. Aliment Pharmacol Ther.
47:922–939. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qian XX, Cai CW, Li HY, Lai LJ, Song DJ,
Qiao YQ, Shen J and Ran ZH: Transcribed ultraconserved region
(T-UCR) uc.261 expression is closely correlated with disease
activity and intestinal permeability in Crohn's disease. Ther Adv
Gastroenter. 12:17562848198807332019.PubMed/NCBI
|
|
23
|
Guo BJ, Bian ZX, Qiu HC, Wang YT and Wang
Y: Biological and clinical implications of herbal medicine and
natural products for the treatment of inflammatory bowel disease.
Ann N Y Acad Sci. 1401:37–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suh SY and An WG: Systems pharmacological
approach of pulsatillae radix on treating Crohn's disease. Evid
Based Complement Alternat Med. 2017:41980352017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Q, Su CP, Zhang HM, Ren YL, Wang W
and Guo SZ: Anti-inflammatory mechanism of heat-clearing and
detoxifying Chinese herbs. Zhongguo Zhong Yao Za Zhi. 43:3787–3794.
2018.(In Chinese). PubMed/NCBI
|
|
26
|
Li S, Li X, Yang R, Wang B, Li J, Cao L,
Xiao S and Huang W: Effects of anemoside B4 on pharmacokinetics of
florfenicol and mRNA expression of CXR, MDR1, CYP3A37 and UGT1E in
broilers. J Vet Med Sci. 81:1804–1809. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi Y, Zhao M, Yao H, Yang P, Xin T, Li B,
Sun W and Chen S: Rapidly discriminate commercial medicinal
Pulsatilla chinensis (Bge.) Regel from its adulterants using ITS2
barcoding and specific PCR-RFLP assay. Sci Rep. 7:400002017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Frisardi V, Panza F, Seripa D, Farooqui T
and Farooqui AA: Glycerophospholipids and
glycerophospholipid-derived lipid mediators: A complex meshwork in
Alzheimer's disease pathology. Prog Lipid Res. 50:313–330. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tatiya-Aphiradee N, Chatuphonprasert W and
Jarukamjorn K: Immune response and inflammatory pathway of
ulcerative colitis. J Basic Clin Physiol Pharmacol. 30:1–10. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Salem HA and Wadie W: Effect of Niacin on
Inflammation and Angiogenesis in a Murine Model of Ulcerative
Colitis. Sci Rep. 7:71392017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leung VSY, Benoit-Biancamano MO and Pang
DSJ: Performance of behavioral assays: The Rat Grimace Scale,
burrowing activity and a composite behavior score to identify
visceral pain in an acute and chronic colitis model. Pain Rep.
4:e7182019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hanauer SB: Oral or topical 5-ASA in
ulcerative colitis. Dig Dis. 34:122–124. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lai LJ, Shen J and Ran ZH: Natural killer
T cells and ulcerative colitis. Cell Immunol. 335:1–5. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chang HK and Hou WS: Retinoic acid
modulates interferon-γ production by hepatic natural killer T cells
via phosphatase 2A and the extracellular signal-regulated kinase
pathway. J Interferon Cytokine Res. 35:200–212. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wu S, Yang C, Xu N, Wang L, Liu Y, Wang J
and Shen X: The protective effects of Helix B surface peptide on
experimental acute liver injury induced by carbon tetrachloride.
Dig Dis Sci. 62:1537–1549. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Tschumi BO, Corgnac S, Rüegg MA,
Hall MN, Mach JP, Romero P and Donda A: Mammalian target of
rapamycin complex 1 orchestrates invariant NKT cell differentiation
and effector function. J Immunol. 193:1759–1765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Landy J, Ronde E, English N, Clark SK,
Hart AL, Knight SC, Ciclitira PJ and Al-Hassi HO: Tight junctions
in inflammatory bowel diseases and inflammatory bowel disease
associated colorectal cancer. World J Gastroenterol. 22:3117–3126.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen T, Xue H, Lin R and Huang Z: MiR-34c
and PlncRNA1 mediated the function of intestinal epithelial barrier
by regulating tight junction proteins in inflammatory bowel
disease. Biochem Biophys Res Commun. 486:6–13. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He C, Deng J, Hu X, Zhou S, Wu J, Xiao D,
Darko KO, Huang Y, Tao T, Peng M, et al: Vitamin A inhibits the
action of LPS on the intestinal epithelial barrier function and
tight junction proteins. Food Funct. 10:1235–1242. 2019. View Article : Google Scholar : PubMed/NCBI
|
